GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma

Numerous studies have implicated Gα-interacting, vesicle-associated protein (GIV) in the development and metastasis of various cancers. However, its role remains unclear in liver hepatocellular carcinoma (LIHC). We aimed to demonstrate the relationship between GIV and LIHC based on The Cancer Genome...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Zhenzhen, Sun, Yibin, Wang, Lin, Ma, Sai, Sun, Chunrong, Zhou, Yu, Yang, Guorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371552/
https://www.ncbi.nlm.nih.gov/pubmed/35960100
http://dx.doi.org/10.1097/MD.0000000000029645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371552/
https://www.ncbi.nlm.nih.gov/pubmed/35960100
http://dx.doi.org/10.1097/MD.0000000000029645

Ejemplares similares